Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, et al..
Renin–angiotensin–aldosterone system inhibitors and risk of covid-19.
N Engl J Med 2020;382:18 de junio. [Ref.ID 103604]